CAMPR-II: A real-world look at a membrane wrap or a polymer wound matrix for hard-to-heal foot ulcers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses a multicenter, hybrid platform design to compare two treatment products against retrospective controls. Prospective participants receive either Membrane Wrap - Hydro or Microlyte Matrix, in addition to standard wound-care practices. The trial collects real-world evidence from patients with nonhealing ulcers, using a coarsened exact matched retrospective control group drawn from the US Wound Registry. Outcomes include wound closure, infections, hospitalizations, and patient-reported outcomes when available.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Male or female 18 years of age and older
2. If a female is not currently pregnant or breastfeeding nor plans to become pregnant during the study and is either not of childbearing potential (defined as: postmenopausal \[defined as amenorrhea for at least 1 year and serum follicle stimulating hormone (FSH) level \>40 IU/L\], or surgically sterile \[bilateral oophorectomy, bilateral salpingectomy, hysterectomy, or tubal ligation at least 6 months prior to IP administration\]), or is practicing one or more of the following medically acceptable methods of birth control throughout the study.

   1. Hormonal methods such as oral, implantable, injectable, vaginal ring, or transdermal contraceptives for a minimum of 1 full cycle (based on subject's usual menstrual cycle period) before Screening/Randomization Visit and must follow that product's package insert instructions including additional protection at times when hormonal contraceptive doses might be missed.
   2. Total abstinence from sexual activities that can lead to pregnancy for at least 6 months prior to Screening/Randomization Visit. Abstinence is acceptable when it is in line with the subject's preferred and usual lifestyle.
   3. Intrauterine device
   4. Vasectomized Partner (for at least 6 months)
   5. Double-barrier method (condoms and clerical cap with spermicidal jellies or cream or condoms and diaphragm with spermicidal jellies or cream or condoms and contraceptive foam).
3. Negative pregnancy test for all subjects of childbearing potential
4. Subjects having a non-healing venous leg ulcer or diabetic foot ulcer of \>4 weeks duration.
5. No visible signs of healing objectively, less than 50% reduction in wound size in the last 4 weeks
6. Subjects' wound size is minimum of 2 cm2 and maximum of 24cm2
7. If the subject has more than one eligible wound the largest wound will be selected (the index wound)
8. Subject is able and willing to follow the protocol requirements
9. Subject has signed informed consent.

Exclusion Criteria:

1. Inability to adhere to the study protocol or study visit schedule
2. Pregnancy
3. Child-bearing potential without appropriate contraception
4. Lactation
5. Treatment of the wound with engineered tissue or other scaffold materials within 30 days preceding the first treatment visit.
6. Visible signs of improvement in the four weeks before randomisation (defined objectively as a 50% reduction in surface area in the four weeks before enrolment)
7. The subject has other concurrent conditions that in the opinion of the investigator may compromise subject safety
8. Known contraindications to the use of either IP1 or IP2
9. The index ulcer shows clinical signs and symptoms of wound infection needing treatment with local or systemic antimicrobials or antibiotics.

Where it's running

• North Park Podiatry
  San Diego, California, United States Recruiting
• Solutions Medical Research
  Coral Gables, Florida, United States Recruiting
• NAR Medical and Research
  Miami, Florida, United States Recruiting
• Nova Medical Services - Research Division LLC
  Miami, Florida, United States Recruiting
• Indiana University Health Methodist Hospital
  Indianapolis, Indiana, United States Recruiting
• St. Louis Foot and Ankle, LLC
  St Louis, Missouri, United States Recruiting

Study contacts

• Study coordinator: Marissa Docter, RN, BSN, MD
• Email: mdocter@capsicure.com
• Phone: 512-571-2966

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Combination Bionerv E+ vs Vitamin B Complex in Type 2 Diabetes with DSPN and Foot Ulcers

  In people with type 2 diabetes and diabetic polyneuropathy, this study tests whether adding alpha-lipoic acid and vitamin E to a vitamin B mix helps nerve symptoms and wound healing better than the vitamin B mix alone.

  Recruiting BREGO Life Sciences · Cheras, Kuala Lumpur · NCT07877948

• DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman

  A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.

  Recruiting Oman Ministry of Health · Muscat · NCT07815275

• Wound gel for diabetic foot ulcers compared with standard care

  This study tests whether the investigational VES-0-D wound gel helps heal mild to moderate diabetic foot ulcers better than standard treatment.

  Recruiting Flen Health · Bonheiden, Antwerp and 7 other locations · NCT07783087

• High-Purity Collagen Skin Substitute vs Fish Skin Matrix for Diabetic Foot Ulcers

  This study tests whether a high-purity type-I collagen skin substitute works better than an acellular fish-skin matrix, when added to standard wound care, for healing diabetic foot ulcers.

  Recruiting at 4 sites Adichunchanagiri Institute of Medical Sciences, B G Nagara · Dhaka and 3 other locations · NCT07781917

• L-Carnitine as an add-on for healing diabetic foot ulcers

  This study tests whether taking L-Carnitine helps wound healing in adults with diabetic foot ulcers, alongside standard diabetes and wound care.

  Recruiting Phase 2 Ain Shams University · Cairo, Cairo Governorate and 1 other locations · NCT07768228

• Coordinated primary-care MDT approach for hard-to-heal ulcers

  A group of adults with hard-to-heal diabetic foot ulcers will be randomly assigned to standard care or a coordinated multidisciplinary team to see if the team approach helps ulcers heal better.

  Recruiting Nordsjaellands Hospital · Hillerød · NCT07747896

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.